Target intelligence / Profile preview

Cellular biomolecules – non-specific oxidative damage

Molecular classification
Other
01

Overview

Cellular biomolecules – non-specific oxidative damage refers to the cumulative chemical degradation of essential cellular components, including DNA, proteins, and lipids, by reactive oxygen species (ROS) and reactive nitrogen species (RNS) (Pizzino et al., 2017, Oxidative Medicine and Cellular Longevity). This phenomenon occurs when the balance between ROS production and endogenous antioxidant defenses is disrupted, leading to a state of oxidative stress (Sies, 2015, Redox Biology). DNA damage often manifests as base modifications like 8-OHdG, which can lead to mutagenesis, while lipid peroxidation compromises cell membrane fluidity and integrity (Halliwell & Gutteridge, 2015, Free Radicals in Biology and Medicine). In proteins, oxidative damage typically results in carbonylation or the loss of thiol groups, which impairs enzymatic activity and structural stability. This broad-spectrum damage is implicated in the pathogenesis of numerous conditions, including Alzheimer's disease, atherosclerosis, and chronic inflammation (NIH, 2022, National Institute on Aging). While drugs like Edaravone or N-acetylcysteine aim to mitigate these effects by scavenging radicals, the non-specific nature of the damage makes it a difficult therapeutic target for precision medicine, as ROS also play vital roles in physiological signaling (StatPearls, 2023, Free Radicals).

Other names
Oxidative stressROS-mediated damageOxidative injuryFree radical damage to biomoleculesRedox imbalance
02

Mechanism of action

Neutralization of reactive oxygen species (ROS) and reactive nitrogen species (RNS) through direct chemical scavenging or enhancement of endogenous antioxidant enzyme systems to prevent the oxidation of lipids, proteins, and nucleic acids.

03

Biological functions

Other
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationAgingOther
05

Safety considerations

Interference with essential physiological redox signalingPotential pro-oxidant effects at high dosesLack of tissue and molecule specificityPoor clinical translation and efficacy of non-specific antioxidants
06

Interacting drugs

Edaravone

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonyl groupsF2-isoprostanesGlutathione disulfide (GSSG) to Glutathione (GSH) ratio

Beyond the preview

Go deeper on Cellular biomolecules – non-specific oxidative damage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular biomolecules – non-specific oxidative damage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call